View in EDS

Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria.

Saved in:

Bibliographic Details
Title:	Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria.
Authors:	Takahashi, Hidetoshi¹ (AUTHOR), Fukunaga, Atsushi² (AUTHOR), Hayama, Koremasa³ (AUTHOR), Sasajima, Takayoshi⁴ (AUTHOR), Fujishige, Ayako⁴ (AUTHOR), Ichishita, Ryohei⁴ (AUTHOR), Tomimatsu, Naoko⁴ (AUTHOR), Hua, Eva⁵ (AUTHOR), Varanasi, Vineeth⁶ (AUTHOR), Burciu, Alis⁷ (AUTHOR), Hide, Michihiro^1,8,9 (AUTHOR) ed1h-w1de-road@hiroshima-u.ac.jp, Severin, Thomas⁷ (AUTHOR)
Source:	Allergology International. Jan2025, Vol. 74 Issue 1, p136-143. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	13238930
DOI:	10.1016/j.alit.2024.09.002